These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31364594)

  • 1. Rational combinations of immunotherapy with radiotherapy in ovarian cancer.
    Herrera FG; Irving M; Kandalaft LE; Coukos G
    Lancet Oncol; 2019 Aug; 20(8):e417-e433. PubMed ID: 31364594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunotherapy for the treatment of head and neck cancer.
    Karam SD; Raben D
    Lancet Oncol; 2019 Aug; 20(8):e404-e416. PubMed ID: 31364593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy.
    Deutsch E; Chargari C; Galluzzi L; Kroemer G
    Lancet Oncol; 2019 Aug; 20(8):e452-e463. PubMed ID: 31364597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial ovarian cancer: the role of radiotherapy.
    Dembo AJ
    Int J Radiat Oncol Biol Phys; 1992; 22(5):835-45. PubMed ID: 1555974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?
    Walshaw RC; Honeychurch J; Illidge TM
    Br J Radiol; 2016 Oct; 89(1066):20160472. PubMed ID: 27556933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials exploring the benefit of immunotherapy and radiation in cancer treatment: A review of the past and a look into the future.
    Naghavi AO; Johnstone PA; Kim S
    Curr Probl Cancer; 2016; 40(1):38-67. PubMed ID: 26656977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership.
    Chajon E; Castelli J; Marsiglia H; De Crevoisier R
    Crit Rev Oncol Hematol; 2017 Mar; 111():124-132. PubMed ID: 28259287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy and Radiation: Charting a Path Forward Together.
    Sridharan V; Schoenfeld JD
    Hematol Oncol Clin North Am; 2019 Dec; 33(6):1057-1069. PubMed ID: 31668206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for ovarian cancer: recent advances and perspectives.
    Zsiros E; Tanyi J; Balint K; Kandalaft LE
    Curr Opin Oncol; 2014 Sep; 26(5):492-500. PubMed ID: 25036883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of radiation and immunotherapy in breast cancer - Treatment implications.
    Ye JC; Formenti SC
    Breast; 2018 Apr; 38():66-74. PubMed ID: 29253718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
    Shahabi V; Postow MA; Tuck D; Wolchok JD
    Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy.
    Serre R; Benzekry S; Padovani L; Meille C; André N; Ciccolini J; Barlesi F; Muracciole X; Barbolosi D
    Cancer Res; 2016 Sep; 76(17):4931-40. PubMed ID: 27302167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure.
    Corn BW; Lanciano RM; Boente M; Hunter WM; Ladazack J; Ozols RF
    Cancer; 1994 Dec; 74(11):2979-83. PubMed ID: 7525039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the role of radiotherapy in ovarian cancer.
    Lanciano R; Reddy S; Corn B; Randall M
    Semin Oncol; 1998 Jun; 25(3):361-71. PubMed ID: 9633849
    [No Abstract]   [Full Text] [Related]  

  • 15. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy.
    Lee S; Son B; Park G; Kim H; Kang H; Jeon J; Youn H; Youn B
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?
    Wirsdörfer F; de Leve S; Jendrossek V
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer.
    Einhorn N
    Acta Oncol; 1996; 35 Suppl 7():86-92. PubMed ID: 9154100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer.
    Dinniwell R; Lock M; Pintilie M; Fyles A; Laframboise S; Depetrillo D; Levin W; Manchul L; Murphy J; Oza A; Rosen B; Sturgeon J; Milosevic M
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):104-10. PubMed ID: 15850909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.